Genomics Bioscience & Technology Co (4195.TWO) Stock Price

Genomics Bioscience & Technology Co Price

CLOSED
14.40
+1.40 (+10.22 %)
Market closed

Over the last 15 years Genomics Bioscience & Technology Co grew revenue by 15.5% annually, reaching 708.38 M TWD. Earnings per share have grown at 8.3% per year over the last 11 years. For Genomics Bioscience & Technology Co, the net margin of -5.6% is down versus 4.8% a few years ago. At today's price the dividend yield works out to roughly 0.69%. The stock trades about 12% above its 52-week low.

Genomics Bioscience & Technology Co stock price

Access this data via the Eulerpool API

Genomics Bioscience & Technology Co business model & stock analysis

Frequently asked questions about Genomics Bioscience & Technology Co

Converted at the current exchange rate, the Genomics Bioscience & Technology Co share trades at 0.40 EUR (14.40 TWD).

No history available for Genomics Bioscience & Technology Co.

The revenue cannot currently be calculated for Genomics Bioscience & Technology Co.

The profit cannot currently be calculated for Genomics Bioscience & Technology Co.

The P/E ratio cannot be calculated for Genomics Bioscience & Technology Co at the moment.

The P/S cannot be calculated for Genomics Bioscience & Technology Co currently.

The Eulerpool Quality Score for Genomics Bioscience & Technology Co is 3/10.

The ISIN of Genomics Bioscience & Technology Co is TW0004195003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Genomics Bioscience & Technology Co is 4195.TWO. The ticker symbol is used to trade Genomics Bioscience & Technology Co shares on the stock exchange.

The current dividend yield of Genomics Bioscience & Technology Co is 0.69 %.

Genomics Bioscience & Technology Co paid dividends every year for the past 0 years.

Genomics Bioscience & Technology Co is assigned to the 'Health' sector.

To receive the latest dividend of Genomics Bioscience & Technology Co from 9/8/2023 amounting to 0.1 TWD, you needed to have the stock in your portfolio before the ex-date on 8/8/2023.

The last dividend was paid out on 9/8/2023.

In the year 2023, Genomics Bioscience & Technology Co distributed 0.1 TWD as dividends.

The dividends of Genomics Bioscience & Technology Co are distributed in TWD.

Fair ValueTerminal
12.24 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Dec 16, 2013
ISIN
TW0004195003
Cusip
Y26935109
Market capitalization
1.04 B TWDSmall Cap
52-Week Range
12.90–27.75TWD
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.04
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-4.86 %
Gross Margin
32.66 %
EBIT Margin
-10.53 %
Net Margin
-5.57 %
EPS (Earnings Per Share)
-0.54 TWD
Net Debt / EBIT
-2.19
Debt/Equity
0.59
Dividend
Dividend yield
0.00 %
Payout Ratio
0.00 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Sep 27, 2026, 6:22 PM

Genomics Bioscience & Technology Co Peer Group

Genomics Bioscience & Technology Co FIGI

4195:TT (Taipei Stock Exchange) · BBG005N22ZK6